Thanks to Philadelphia personal injury lawyer Jamie Sheller for bringing to my attention a Public Health Advisory from the FDA. Last week, the agency announced a study in the New England Journal of Medicine has linked ACE inhibitors to an increased risk of birth defects when used in a woman’s first trimester of pregnancy. ACE inhibitors are often prescribed to lower blood pressure – by blocking an enzyme which causes blood vessels to narrow and constrict – in patients suffering hypertension.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.